Answers are grounded in this paper and cite their sources.
A systematic review of randomized and observational studies from 2013 to 2023 demonstrated that antiviral preemptive therapy started at cytomegalovirus viral load thresholds between 2 and 3 log10 IU/mL was associated with similar cytomegalovirus disease rates. Thus, viral thresholds in this range appear to effectively protect patients not receiving prophylaxis.
No takes yet. Share an insight, caveat, or question.
Sadowska‐Klasa et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: